News
Careers
Contact
Aerio
Features
Intellectual Property
Partnering
Medical Countermeasures
Request a Meeting
Products
Pipeline
Our Commitment
About
Leadership
Integrity & Compliance
Medical Countermeasures
News
Careers
Contact
Aerio
Features
Intellectual Property
Partnering
Medical Countermeasures
Request a Meeting
Products
Pipeline
Our Commitment
About
Leadership
Integrity & Compliance
Medical Countermeasures
News
Careers
Contact
News
Media Contact
media.inquiries@kaleo.com
News Archive
July 10, 2014
EVZIO™ (naloxone HCl injection) Auto-Injector Now Available in the United States for the Emergency Treatment of Opioid Overdose
April 7, 2014
Kaléo announces $150 million debt financing to support commercialization of EVZIO™
April 3, 2014
FDA Approves Kaleo’s EVZIO™ for the Emergency Treatment of Opioid Overdose
January 6, 2014
Intelliject, Inc. announces name change to Kaléo
November 14, 2013
Intelliject, Inc. wins prestigious medication safety award
May 29, 2012
Intelliject, Inc. announces $15 million debt financing to accelerate targeted pipeline development
«
1
2
3
4
